AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35841235 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA vaccine (M group)
Number of subjects: 85
Study 35841235 — intervention group
Group type: COMPARATOR
Intervention: Viral vector vaccine (V group)
Number of subjects: 85
Study 34323924 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (2000 mg/d) during chemoradiotherapy and afterward for up to 12 months
Number of subjects: 54
Study 34323924 — intervention group
Group type: COMPARATOR
Intervention: Control (platinum-based chemotherapy with concurrent chest radiotherapy)
Number of subjects: 54
Study 34323924 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin arm
Number of subjects: 54
Study 34323924 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 54
Study 34541752 — intervention group
Group type: EXPERIMENTAL
Intervention: Earplugs (between 10 pm and 7 am on the second night of ICU stay)
Number of subjects: 107
Study 34541752 — intervention group
Group type: COMPARATOR
Intervention: No earplugs (control group)
Number of subjects: 107
Study 32302009 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mmol kg-1 gadopiclenol
Number of subjects: 48
Study 32302009 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mmol kg-1 gadopiclenol
Number of subjects: 48
Study 32302009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 32302009 — intervention group
Group type: COMPARATOR
Intervention: 400 mg moxifloxacin
Number of subjects: 48
Study 35583055 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg 5-HTP daily
Number of subjects: 61
Study 35583055 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 61
Study 35583055 — intervention group
Group type: COMPARATOR
Intervention: Comparison between 5-HTP and placebo
Number of subjects: 61
Study 33298762 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptococcus salivarius K12 probiotic for 1 month
Number of subjects: 121
Study 33298762 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 121
Study 32698766 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized fluid management (IFM)
Number of subjects: 300
Study 32698766 — intervention group
Group type: COMPARATOR
Intervention: Standard fluid management (Control)
Number of subjects: 300
Study 35489304 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral erector spinae plane block (ESPB) with bupivacaine
Number of subjects: 40
Study 35489304 — intervention group
Group type: COMPARATOR
Intervention: No block (Control Group C)
Number of subjects: 40
Study 33588377 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex-Paired Training (CPT, n = 9)
Number of subjects: 17
Study 33588377 — intervention group
Group type: COMPARATOR
Intervention: Reverse-Contrast Training (RCT, n = 8)
Number of subjects: 17
Study 32062860 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative medication checklist
Number of subjects: 35
Study 32062860 — intervention group
Group type: COMPARATOR
Intervention: Control group (post-operative pain medication plus VAS form)
Number of subjects: 35
Study 32062860 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 35
Study 36193575 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus 4-hour monitoring (C4)
Number of subjects: 50
Study 36193575 — intervention group
Group type: COMPARATOR
Intervention: Trough monitoring (C0)
Number of subjects: 50
Study 34267272 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise (downhill walking) 3-5 times per week for 2 months
Number of subjects: 127
Study 34267272 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control group
Number of subjects: 127
Study 32605389 — intervention group
Group type: EXPERIMENTAL
Intervention: Contemporaneous transabdominal rigid ureteroscopy (TRU)
Number of subjects: 45
Study 32605389 — intervention group
Group type: COMPARATOR
Intervention: Postoperative extracorporeal shockwave lithotripsy (SWL)
Number of subjects: 45
Study 35063244 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry group (500 mg dry cranberry extract, 2 times daily for 2 months)
Number of subjects: 25
Study 35063244 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (500 mg corn starch, 2 times daily for 2 months)
Number of subjects: 25
Study 34032479 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose IV administration of MMF (2.5 mg/kg)
Number of subjects: 12
Study 34032479 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose PO administration of MMF (5 mg/kg)
Number of subjects: 12
Study 34032479 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term PO administration of MMF (5 mg/kg, PO, q 24 h for 30 days and then 5 mg/kg, PO, q 48 h for an additional 30 days)
Number of subjects: 12
Study 35675525 — intervention group
Group type: EXPERIMENTAL
Intervention: Solithromycin
Number of subjects: 97
Study 35675525 — intervention group
Group type: COMPARATOR
Intervention: Comparator
Number of subjects: 97
Study 35192970 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisternostomy
Number of subjects: 50
Study 35192970 — intervention group
Group type: COMPARATOR
Intervention: Decompressive Craniectomy
Number of subjects: 50
Study 32344403 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral Left Nostril Breathing (ULNB) for 15 min
Number of subjects: 20
Study 32344403 — intervention group
Group type: COMPARATOR
Intervention: Breath awareness for 15 min (Control)
Number of subjects: 20
Study 32344403 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral Left Nostril Breathing (ULNB)
Number of subjects: 20
Study 32344403 — intervention group
Group type: COMPARATOR
Intervention: Breath awareness (Control)
Number of subjects: 20
Study 34328481 — intervention group
Group type: EXPERIMENTAL
Intervention: SLA surface implants (Group 1)
Number of subjects: 37
Study 34328481 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorine-modified surface implants (Group 2)
Number of subjects: 37
Study 34328481 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodized surface implants (Group 3)
Number of subjects: 37
Study 34328481 — intervention group
Group type: COMPARATOR
Intervention: Comparative analysis of all groups
Number of subjects: 37
Study 33132344 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g RMD three times daily
Number of subjects: 140
Study 33132344 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage without RMD
Number of subjects: 140
Study 36214230 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided trigger point injection (TPI)
Number of subjects: 196
Study 36214230 — intervention group
Group type: COMPARATOR
Intervention: NSAID plus muscle relaxant (MR)
Number of subjects: 196
Study 32666079 — intervention group
Group type: EXPERIMENTAL
Intervention: Canakinumab (CANTOS trial)
Number of subjects: 0
Study 32666079 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine (COLCOT trial)
Number of subjects: 0
Study 32666079 — intervention group
Group type: COMPARATOR
Intervention: Other anti-inflammatory treatments (e.g., methotrexate in Cardiovascular Inflammation Reduction Trial)
Number of subjects: 0
Study 32957334 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper limbs endurance strengthening (group E)
Number of subjects: 280
Study 32957334 — intervention group
Group type: COMPARATOR
Intervention: Upper limbs force strengthening (group F)
Number of subjects: 280
Study 36167936 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component intervention (neck exercises, health-promotion information, workplace ergonomics) over 12 weeks
Number of subjects: 120
Study 36167936 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned in the abstract)
Number of subjects: 120
Study 33413874 — intervention group
Group type: EXPERIMENTAL
Intervention: Transanal tube insertion
Number of subjects: 157
Study 33413874 — intervention group
Group type: COMPARATOR
Intervention: No transanal tube insertion
Number of subjects: 157
Study 36138497 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (early stages)
Number of subjects: 20
Study 36138497 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (advanced stages)
Number of subjects: 20
Study 35134961 — intervention group
Group type: EXPERIMENTAL
Intervention: Cartridge-based e-vapor product (classic, 4% nicotine)
Number of subjects: 450
Study 35134961 — intervention group
Group type: EXPERIMENTAL
Intervention: Cartridge-based e-vapor product (menthol, 4% nicotine)
Number of subjects: 450
Study 35134961 — intervention group
Group type: EXPERIMENTAL
Intervention: Cartridge-based e-vapor products (both tests)
Number of subjects: 450
Study 35134961 — intervention group
Group type: COMPARATOR
Intervention: Control (continued smoking)
Number of subjects: 450
Study 32130160 — intervention group
Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) classifiers for nonmedical use
Number of subjects: 6860
Study 32130160 — intervention group
Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) classifiers for side effects
Number of subjects: 6860
Study 35105251 — intervention group
Group type: EXPERIMENTAL
Intervention: Derotational breathing
Number of subjects: 24
Study 35105251 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 24
Study 35105251 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal breathing
Number of subjects: 24
Study 33345573 — intervention group
Group type: EXPERIMENTAL
Intervention: PET-CT
Number of subjects: 25
Study 33345573 — intervention group
Group type: COMPARATOR
Intervention: No PET-CT
Number of subjects: 25
Study 33345573 — intervention group
Group type: EXPERIMENTAL
Intervention: EHD
Number of subjects: 25
Study 32798840 — intervention group
Group type: EXPERIMENTAL
Intervention: mNGF
Number of subjects: 60
Study 32798840 — intervention group
Group type: COMPARATOR
Intervention: citicoline (control)
Number of subjects: 60
Study 35855848 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible ureteroscopy
Number of subjects: 78
Study 33687587 — intervention group
Group type: EXPERIMENTAL
Intervention: CPT1A rs2846194
Number of subjects: 334
Study 33687587 — intervention group
Group type: EXPERIMENTAL
Intervention: CPT1A rs2602814
Number of subjects: 334
Study 33687587 — intervention group
Group type: EXPERIMENTAL
Intervention: CPT1A rs59506005
Number of subjects: 334
Study 33687587 — intervention group
Group type: EXPERIMENTAL
Intervention: GGAC haplotype (rs17399246 rs1016873 rs11228450 rs10896396)
Number of subjects: 334
Study 35719613 — intervention group
Group type: EXPERIMENTAL
Intervention: pTNM staging system
Number of subjects: 236
Study 35719613 — intervention group
Group type: EXPERIMENTAL
Intervention: Age at diagnosis
Number of subjects: 236
Study 35719613 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms based on pTNM, age, and tumor grade
Number of subjects: 236
Study 35719613 — intervention group
Group type: COMPARATOR
Intervention: Comparison with Sheldon and Mayo staging systems
Number of subjects: 236
Study 33932527 — intervention group
Group type: EXPERIMENTAL
Intervention: Gratitude writing intervention
Number of subjects: 61
Study 33932527 — intervention group
Group type: COMPARATOR
Intervention: Control writing intervention
Number of subjects: 61
Study 34224601 — intervention group
Group type: EXPERIMENTAL
Intervention: Acoustic subcision treatment
Number of subjects: 56
Study 33479759 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-Mental State Examination scores (MMSE)
Number of subjects: 330
Study 33479759 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance status
Number of subjects: 330
Study 33479759 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex
Number of subjects: 330
Study 33479759 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronological age
Number of subjects: 330
Study 36967704 — intervention group
Group type: EXPERIMENTAL
Intervention: Previsit glaucoma video/question prompt list intervention
Number of subjects: 189
Study 36967704 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 189
Study 33581971 — intervention group
Group type: EXPERIMENTAL
Intervention: SOC + IPSP
Number of subjects: 399
Study 33581971 — intervention group
Group type: COMPARATOR
Intervention: SOC
Number of subjects: 399
Study 35537314 — intervention group
Group type: EXPERIMENTAL
Intervention: Satralizumab (120 mg subcutaneous)
Number of subjects: 16
Study 35537314 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid tapering
Number of subjects: 16
Study 35537314 — intervention group
Group type: COMPARATOR
Intervention: Satralizumab
Number of subjects: 16
Study 34120149 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibudilast
Number of subjects: 52
Study 34120149 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 35240552 — intervention group
Group type: EXPERIMENTAL
Intervention: Pink noise
Number of subjects: 16
Study 35240552 — intervention group
Group type: COMPARATOR
Intervention: White noise
Number of subjects: 16
Study 35240552 — intervention group
Group type: COMPARATOR
Intervention: Chaotic signals
Number of subjects: 16
Study 35240552 — intervention group
Group type: COMPARATOR
Intervention: No-stimulation condition
Number of subjects: 16
Study 32186272 — intervention group
Group type: EXPERIMENTAL
Intervention: Tree nuts and peanuts
Number of subjects: 0
Study 35412564 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based walking exercise behavior change intervention
Number of subjects: 190
Study 35412564 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 190
Study 34116009 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluation of IOL rotational stability using nontoric implants in 25 patients with 2 consecutive follow-up visits.
Number of subjects: 25
Study 32654212 — intervention group
Group type: EXPERIMENTAL
Intervention: Inotersen 300 mg weekly for 65 weeks
Number of subjects: 0
Study 32654212 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35243125 — intervention group
Group type: EXPERIMENTAL
Intervention: Floating (resting in a supine immersed position on flotation devices)
Number of subjects: 24
Study 35243125 — intervention group
Group type: EXPERIMENTAL
Intervention: WATSU (a passive hands-on treatment in warm water)
Number of subjects: 24
Study 35243125 — intervention group
Group type: EXPERIMENTAL
Intervention: Spa session
Number of subjects: 24
Study 32152774 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic/robotic extraperitoneal paraaortic staging
Number of subjects: 634
Study 32152774 — intervention group
Group type: COMPARATOR
Intervention: Imaging staging (control group)
Number of subjects: 634
Study 32152774 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival and cancer-specific disease-free survival
Number of subjects: 634
Study 32152774 — intervention group
Group type: EXPERIMENTAL
Intervention: Time interval between diagnosis and starting EFRT
Number of subjects: 634
Study 616782981 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation anesthesia combined with nerve block
Number of subjects: 65
Study 36198383 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended lymphadenectomy
Number of subjects: 170
Study 36198383 — intervention group
Group type: COMPARATOR
Intervention: Standard lymphadenectomy
Number of subjects: 170
Study 36198383 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 170
Study 34469764 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for atrial fibrillation
Number of subjects: 28768
Study 34469764 — intervention group
Group type: COMPARATOR
Intervention: Control group (no screening)
Number of subjects: 28768
Study 35596008 — intervention group
Group type: EXPERIMENTAL
Intervention: Sesame–Canola Oil (SCO)
Number of subjects: 282
Study 34890355 — intervention group
Group type: EXPERIMENTAL
Intervention: SWiPE app intervention
Number of subjects: 1309
Study 34958176 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent Participation in Postoperative Pain Management Program
Number of subjects: 413
Study 34958176 — intervention group
Group type: COMPARATOR
Intervention: Routine postoperative pain management
Number of subjects: 413
Study 32133503 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk (600 mL)
Number of subjects: 11
Study 32133503 — intervention group
Group type: EXPERIMENTAL
Intervention: Cheese (100 g)
Number of subjects: 11
Study 32133503 — intervention group
Group type: COMPARATOR
Intervention: Soy-based drink (600 mL)
Number of subjects: 11
Study 36121672 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (500 mg intravenous infusion)
Number of subjects: 87
Study 36121672 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 36121672 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 87
Study 34101234 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-mm abutment
Number of subjects: 65
Study 34101234 — intervention group
Group type: COMPARATOR
Intervention: 1-mm abutment
Number of subjects: 65
Study 35797804 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive virtual reality rehabilitation (Oculus Rift), 12 sessions over 4 weeks
Number of subjects: 20
Study 34314018 — intervention group
Group type: EXPERIMENTAL
Intervention: belantamab mafodotin (belamaf) 2.5 mg/kg
Number of subjects: 97
Study 32891287 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive games
Number of subjects: 172
Study 32891287 — intervention group
Group type: EXPERIMENTAL
Intervention: Painting
Number of subjects: 172
Study 32891287 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 172
Study 35371086 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone + Methotrexate (MTX) 10 mg orally every week
Number of subjects: 40
Study 35371086 — intervention group
Group type: COMPARATOR
Intervention: Prednisone alone
Number of subjects: 40
Study 35371086 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone + Methotrexate (MTX)
Number of subjects: 40
Study 32346833 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciproc (R25)
Number of subjects: 81
Study 32346833 — intervention group
Group type: EXPERIMENTAL
Intervention: K‐files (#15‐40)
Number of subjects: 81
Study 32346833 — intervention group
Group type: EXPERIMENTAL
Intervention: ProDesign Logic (#25)
Number of subjects: 81
Study 32910201 — intervention group
Group type: EXPERIMENTAL
Intervention: Caprini RAM
Number of subjects: 442
Study 32910201 — intervention group
Group type: EXPERIMENTAL
Intervention: Khorana score (KS)
Number of subjects: 442
Study 35714077 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-supervised home-based exercise training
Number of subjects: 32
Study 35714077 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 35714077 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 32
Study 32167177 — intervention group
Group type: EXPERIMENTAL
Intervention: Forward conditioning with intense USs
Number of subjects: 0
Study 32167177 — intervention group
Group type: EXPERIMENTAL
Intervention: Backward conditioning with intense USs
Number of subjects: 0
Study 32167177 — intervention group
Group type: EXPERIMENTAL
Intervention: Forward conditioning
Number of subjects: 0
Study 32167177 — intervention group
Group type: EXPERIMENTAL
Intervention: Backward conditioning
Number of subjects: 0
Study 32167177 — intervention group
Group type: EXPERIMENTAL
Intervention: Backward CSs with increasing US pleasantness
Number of subjects: 0
Study 32167177 — intervention group
Group type: EXPERIMENTAL
Intervention: Omission of forward CSs
Number of subjects: 0
Study 33931736 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal voice exposure during neonatal NREM sleep
Number of subjects: 35
Study 33931736 — intervention group
Group type: COMPARATOR
Intervention: Right hemisphere ICOH (C4-Cz; T4-Cz)
Number of subjects: 35
Study 32845522 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestational anaemia
Number of subjects: 182309
Study 32845522 — intervention group
Group type: COMPARATOR
Intervention: Control group (no gestational anaemia)
Number of subjects: 182309
Study 33096999 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted group
Number of subjects: 12
Study 33096999 — intervention group
Group type: COMPARATOR
Intervention: Landmark-guided group
Number of subjects: 12
Study 35469143 — intervention group
Group type: EXPERIMENTAL
Intervention: Barley-based remedy plus conventional medicine
Number of subjects: 70
Study 35469143 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 70
Study 35469143 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 70
Study 33333277 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-transfusion with autologous blood transfusion
Number of subjects: 40
Study 33333277 — intervention group
Group type: COMPARATOR
Intervention: Control group (no self-transfusion)
Number of subjects: 40
Study 36235536 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein (PRO‐HIIT, N = 24)
Number of subjects: 47
Study 32949456 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually prescribed home hazard reduction and home-based exercise program
Number of subjects: 309
Study 32949456 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 309
Study 36379530 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injections
Number of subjects: 30
Study 36379530 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids (CS) injections
Number of subjects: 30
Study 33644953 — intervention group
Group type: EXPERIMENTAL
Intervention: mXELIRI (capecitabine plus irinotecan) with PPI use
Number of subjects: 482
Study 33644953 — intervention group
Group type: COMPARATOR
Intervention: FOLFIRI with PPI use
Number of subjects: 482
Study 33644953 — intervention group
Group type: EXPERIMENTAL
Intervention: mXELIRI without PPI use
Number of subjects: 482
Study 33644953 — intervention group
Group type: COMPARATOR
Intervention: FOLFIRI without PPI use
Number of subjects: 482
Study 33644953 — intervention group
Group type: EXPERIMENTAL
Intervention: mXELIRI with PPI use
Number of subjects: 482
Study 35288599 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.25 mg/kg every 6 hours, 6-12 hours prior to extubation (four doses)
Number of subjects: 147
Study 35288599 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 147
Study 35288599 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study 35750736 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural intervention (theory-based programme)
Number of subjects: 312
Study 35750736 — intervention group
Group type: COMPARATOR
Intervention: Conventional programmes (control)
Number of subjects: 312
Study 32747306 — intervention group
Group type: EXPERIMENTAL
Intervention: ORC-Coll (mediCipio® A)
Number of subjects: 150